Article Information
History
- September 10, 2021.
Article Versions
- Version 1 (January 22, 2021 - 07:37).
- Version 2 (January 24, 2021 - 08:42).
- Version 3 (February 8, 2021 - 13:54).
- Version 4 (May 12, 2021 - 09:01).
- You are viewing Version 5, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Noah A. Haber, ScD1,*,
- Emma Clarke-Deelder, MPhil2,
- Avi Feller, PhD3,
- Emily R. Smith, ScD4,
- Joshua Salomon, PhD5,
- Benjamin MacCormack-Gelles, MS2,
- Elizabeth M. Stone, MS6,
- Clara Bolster-Foucault, MScPH7,
- Jamie R. Daw, PhD8,
- Laura A. Hatfield, PhD9,
- Carrie E. Fry, PhD10,
- Christopher B. Boyer, MPH11,
- Eli Ben-Michael, PhD12,
- Caroline M. Joyce, MPH7,
- Beth S. Linas, PhD, MHS13,14,
- Ian Schmid, ScM15,
- Eric H. Au, MPH16,
- Sarah E. Wieten, PhD1,
- Brooke A Jarrett, MSPH13,
- Cathrine Axfors, MD, PhD1,
- Van Thu Nguyen, PhD1,
- Beth Ann Griffin, PhD17,
- Alyssa Bilinski, MS18 and
- Elizabeth A. Stuart, PhD15
- 1Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, USA
- 2Department of Global Health and Population, Harvard T. H. Chan School of Public Health, Boston, MA, USA
- 3Goldman School of Public Policy, UC Berkeley, Berkeley, CA, USA
- 4Department of Global Health, Milken Institute School of Public Health, George Washington University, Washington, D.C, USA
- 5Center for Health Policy and Center for Primary Care and Outcomes Research, Stanford University, Stanford, CA, USA
- 6Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
- 7Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Canada
- 8Health Policy and Management, Columbia University Mailman School of Public Health, New York, NY, USA
- 9Department of Health Care Policy, Harvard Medical School, Boston, MA, USA
- 10Department of Health Policy, Vanderbilt University, Nashville, TN, USA
- 11Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA
- 12Institute for Quantitative Social Science, Harvard University, Cambridge, MA, USA
- 13Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
- 14Clinical Quality and Informatics, MITRE Corp, McLean, VA, USA
- 15Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
- 16School of Public Health, University of Sydney, Sydney, Australia
- 17RAND Corporation, Arlington, VA, USA
- 18Interfaculty Initiative in Health Policy, Harvard Graduate School of Arts and Sciences, Cambridge, MA, USA
- ↵*Corresponding author: Noah A. Haber, ScD, noahhaber{at}stanford.edu, Meta Research Innovation Center at Stanford University, Stanford University, 1265 Welch Rd, Palo Alto, CA 94305, (650) 497-0811
Posted September 10, 2021.
Problems with Evidence Assessment in COVID-19 Health Policy Impact Evaluation: A systematic review of study design and evidence strength
